Lentivirally generated eGFP-transgenic rats allow efficient cell tracking in vivo

Genesis (United States)

Volumn 39, Issue 2, 2004, Pages 94-99

  Van Den Brandt, Jens ^a   Wang, Dapeng ^a   Kwon, Soon Hwan ^a   Heinkelein, Martin ^a   Reichardt, Holger M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

eGFP transgenic rats; Lentiviruses; Zygotes

Indexed keywords

CD4 ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ARTICLE; CELL TRANSPORT; CELL TYPE; EMBRYO; FLOW CYTOMETRY; FOUNDER EFFECT; GENE EXPRESSION; GENE TRANSFER; GENOME; IMMUNOLOGY; LENTIVIRINAE; LEUKOCYTE; MOSAICISM; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROVIRUS; RAT; T LYMPHOCYTE SUBPOPULATION; TRANSGENE; TRANSGENIC ANIMAL; TRANSGENIC RAT; TRANSGENICS; VIRAL GENE DELIVERY SYSTEM; VIRUS DNA CELL DNA INTERACTION; ZYGOTE;

EID: 3142723251     PISSN: 1526954X     EISSN: None     Source Type: Journal    
DOI: 10.1002/gene.20037     Document Type: Article

References (28)

1. Bader M, Ganten D. 1996. Transgenic rats: tools to study the function of the renin-angiotensin system. Clin Exp Pharmacol Physiol Suppl 3:S81-87.
2. Church GM, Gilbert W. 1984. Genomic sequencing. Proc Natl Acad Sci USA 81:1991-1995.
3. Datson NA, van der Perk J, de Kloet ER, Vreugdenhil E. 2001. Expression profile of 30,000 genes in rat hippocampus using SAGE. Hippocampus 11:430-444.
4. Flügel A, Willem M, Berkowicz T, Wekerle H. 1999. Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses. Nat Med 5:843-847.
5. Flügel A, Berkowicz T, Ritter T, Labeur M, Jenne DE, Li Z, Ellwart JW, Willem M, Lassmann H, Wekerle H. 2001. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14:547-560.
6. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. 1990. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 63:1099-1112.
7. Hamra FK, Gatlin J, Chapman KM, Grellhesl DM, Garcia JV, Hammer RE, Garbers DL. 2002. Production of transgenic rats by lentiviral transduction of male germ-line stem cells. Proc Natl Acad Sci USA 99:14931-14936.
8. Hornum L, Romer J, Markholst H. 2002. The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of Iddm1. Diabetes 51:1972-1979.
9. Hünig T, Torres-Nagel N, Mehling B, Park HJ, Herrmann T. 2001. Thymic development and repertoire selection: the rat perspective. Immunol Rev 184:7-19.
10. Jaenisch R. 1988. Transgenic animals. Science 240:1468-1474.
11. Kacew S, Festing MF. 1996. Role of rat strain in the differential sensitivity to pharmaceutical agents and naturally occurring substances. J Toxicol Environ Health 47:1-30.
12. Keppler OT, Welte FJ, Ngo TA, Chin PS, Patton KS, Tsou CL, Abbey NW, Sharkey ME, Grant RM, You Y, Scarborough JD, Ellmeier W, Littman DR, Stevenson M, Charo IF, Herndier BG, Speck RF, Goldsmith MA. 2002. Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J Exp Med 195:719-736.
13. Klöting I, Berg S, Kovacs P, Voigt B, Vogt L, Schmidt S. 1997. Diabetes and hypertension in rodent models. Ann NY Acad Sci 827:64-84.
14. Kohm AP, Carpentier PA, Anger HA, Miller SD. 2002. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 169:4712-4716.
15. Link H, Xiao BG. 2001. Rat models as tool to develop new immunotherapies. Immunol Rev 184:117-128.
16. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868-872.
17. Metzger D, Chambon P. 2001. Site- and time-specific gene targeting in the mouse. Methods 24:71-80.
18. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM. 1998. Development of a self-inactivating lentivirus vector. J Virol 72:8150-8157.
19. Mullins LJ, Mullins JJ. 1996. Transgenesis in the rat and larger mammals. J Clin Invest 97:1557-1560.
20. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
21. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, Schütz G. 1998. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93:531-541.
22. Reichardt HM, Umland T, Bauer A, Kretz O, Schütz G. 2000. Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock. Mol Cell Biol 20:9009-9017.
23. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Ihrig MM, McManus MT, Gertler FB, Scott ML, Van Parijs L. 2003. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33:401-406.
24. Schinke M, Baltatu O, Bohm M, Peters J, Rascher W, Bricca G, Lippoldt A, Ganten D, Bader M. 1999. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci USA 96:3975-3980.
25. Smialowicz RJ. 2002. The rat as a model in developmental immunotoxicology. Hum Exp Toxicol 21:513-519.
26. Stefferl A, Linington C, Holsboer F, Reul JM. 1999. Susceptibility and resistance to experimental allergic encephalomyelitis: relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat. Endocrinology 140:4932-4938.
27. Swanborg RH. 2001. Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity. Immunol Rev 184:129-135.
28. Zufferey R, Donello JE, Trono D, Hope TJ. 1999. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73:2886-2892.